Shubhi Jain
4 Papers
Shubhi Jain is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Transformational leadership and knowledge sharing behavior in freelancers: A moderated mediation model with employee engagement and social support
Mohit Yadav,Sangita Choudhary,Shubhi Jain +2 more
- 21 Jan 2019
TL;DR: In this paper, the authors explored the relationship between transformational leadership and knowledge sharing behavior in freelancers and found that social support was found to moderate the mediated path by employee engagement.
26
Prospective audit of the phenotype, causes and correlates of trachomatous and non- trachomatous trichiasis in a peri-elimination setting
Noopur Gupta,Praveen Vashist,Rachna Meel,Sumit Grover,Shubhi Jain,Deepak Kumar,Vivek Gupta,Radhika Tandon,Anthony W. Solomon +8 more
TL;DR: The most common attributed cause of upper eyelid trichiasis was trachoma (26% of patients), followed by Stevens-Johnson syndrome (23%), blepharokeratoconjunctivitis (17%), and old age (10%) as mentioned in this paper .
A Review on Umbilical Cord Milking and Its Implications in Neonatal Health
Shubhi Jain,AM Mehendale +1 more
TL;DR: In this paper , the authors examined all the studies relating to umbilical cord milking (UCM) in late-preterm and term infants and evaluated every achievable outcome and restriction of a given process in clinical application, mainly when compared to rapid and late cord clamping, which can be seen to improve the health of hypoxic neonates, weight parameters, blood volume, hemoglobin, iron levels in the blood, red blood cell count, blood pressure, right ventricular output, left ventricular functions, cerebral oxygenation, urine output regulation, cognitive abilities, antioxidant levels, better outcomes in the resuscitation of infant and above all helps in lowering Infant Mortality Rates.
Umbrella Meta-analysis Evaluating the Effectiveness of ViV-TAVI vs Redo SAVR
Surya Aedma,Nida Khan,A. Altamimi,Nawal Ali,Shubhi Jain,Karanrajsinh Raol,Sowmya Madireddy,Jigisha Rakholiya,Abdur Raheem,Rutikbhai Desai,Urvish K Patel,Rizwan Rabbani,Suveenkrishna Pothuru +12 more
TL;DR: A meta-meta-analysis reinforces the safety and efficacy of ViV-TAVR as the procedure of choice for failed bioprosthetic (BP) valves in high-risk candidates as well as reducing the risk of 30-day mortality compared to rSAVR.